Premium
Influence of Multivitamin Regimen on Urinary Oxalate in Home Parenteral Nutrition Patients
Author(s) -
Fairholm Lydia,
Saqui Olivia,
Baun Mary,
Allard Johane
Publication year - 2003
Publication title -
nutrition in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.725
H-Index - 71
eISSN - 1941-2452
pISSN - 0884-5336
DOI - 10.1177/0115426503018005366
Subject(s) - ascorbic acid , medicine , regimen , urinary system , multivitamin , oxalate , parenteral nutrition , gastroenterology , vitamin c , vitamin , food science , chemistry , inorganic chemistry
Background: High urinary oxalate levels have been associated with high ascorbic acid intakes. An alteration in the vitamin regimen for home parenteral nutrition (HPN) patients because of product discontinuation resulted in provision of 500 mg instead of 100 mg ascorbic acid per HPN day. This regimen was associated with high urinary oxalate levels. Purpose: To determine if a switch from a multivitamin regimen containing 500 mg to one containing 100 mg of ascorbic acid daily would reduce urinary oxalate levels. Methods: A 24‐hour urine collection for oxalate was analyzed before switching the vitamin regimen back to 100 mg ascorbic acid and repeated 2 months after the change. A paired t test was conducted to compare measurements at baseline and at 2 months. Results: Overall, 18 patients completed both phases of this observational study. The initial urinary oxalate of 517 ± 63μ mol/day decreased to 425 ± 47 μmol/day after 2 months ( p = .05). However, after applying the exclusion criteria, only 6 patients could be included. The baseline urinary oxalate of 649 ± 106μ mol/day decreased to 391 ± 57 μmol/day after 2 months ( p = .006). Conclusions: A change in the parenteral regimen of HPN patients from 500 mg ascorbic acid to 100 mg ascorbic acid is associated with a decrease in urinary oxalate levels. This suggests that a moderate dose of parenteral ascorbic acid (100 mg/day) may limit urinary oxalate appearance in HPN patients.